Lakefront Biotherapeutics | GLPG - Market Capitalization


Lakefront Biotherapeutics reported EUR1.91B in Market Capitalization this October of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
argenx SE USD 46.65B 13.36B Oct/2026
AstraZeneca USD 215.06B 74.93B Oct/2026
Biogen USD 35.56B 2.19B Oct/2026
Genmab DKK 17.1B 88.06B Jun/2026
Gilead Sciences USD 206.51B 21.7B Oct/2026
GlaxoSmithKline GBP 74.9B 785.69M Oct/2026
GRIFOLS EUR 5.41B 181.49M Jun/2026
Hikma Pharmaceutical USD 4.63B 1.42B Dec/2025
Incyte USD 26.22B 1.63B Oct/2026
Merck EUR 18.98B 27.8B Jun/2026
Neurocrine Biosciences USD 16.95B 3.7B Jun/2026
Novartis USD 266.01B 25.42B Oct/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sanofi EUR 99.83B 8.68B Oct/2026
UCB EUR 46.41B 13.94B Dec/2025
Vertex Pharmaceuticals USD 126.07B 12.49B Jun/2026